Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Demographics and clinical parameters of the study population

From: Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals

Parameters

Mild

Severe

Subjects enrolled

n = 30

n = 15

Median age (range)

39 (18–81)

48 (22–70)

Gender (M/F)

14/16

12/3

Fever, no. (%)

17 (57)

13 (87)

Chills, no. (%)

4 (13)

6 (40)

Cough, no. (%)

15 (50)

7 (47)

Sore throat, no. (%)

16 (53)

5 (33)

Runny nose, no. (%)

5 (17)

2 (13)

Taste loss, no. (%)

21 (70)

5 (33)

Smell loss, no. (%)

17 (57)

6 (40)

Muscle aches, no. (%)

24 (80)

9 (60)

Joint pain, no. (%)

18 (60)

5 (33)

Abdominal pain, no. (%)

2 (7)

1 (7)

Vomit, no. (%)

2 (7)

1 (7)

Diarrhea, no. (%)

4 (13)

6 (40)

Seizures, no. (%)

NIL

NIL

Hypertension, no. (%)

7 (23)

5 (33)

Diabetes, no. (%)

4 (13)

4 (27)

Asthma, no. (%)

1 (3)

1 (7)

Chronic kidney disease, no. (%)

NIL

NIL

Neuro, no. (%)

NIL

NIL

Heart, no. (%)

NIL

1 (7)

Rheumatic fever, no. (%)

NIL

NIL

Corticosteroids, no. (%)

NIL

3 (20)

Antiviral drug, no. (%)

NIL

4 (27)

Required hospitalization no. (%)

NIL

6 (40)

Required mechanical oxygen support no. (%)

NIL

NIL